IL139988A0 - Tumor antigen useful in diagnosis and therapy of prostate and colon cancer - Google Patents

Tumor antigen useful in diagnosis and therapy of prostate and colon cancer

Info

Publication number
IL139988A0
IL139988A0 IL13998899A IL13998899A IL139988A0 IL 139988 A0 IL139988 A0 IL 139988A0 IL 13998899 A IL13998899 A IL 13998899A IL 13998899 A IL13998899 A IL 13998899A IL 139988 A0 IL139988 A0 IL 139988A0
Authority
IL
Israel
Prior art keywords
prostate
tmprss2
diagnosis
therapy
colon cancer
Prior art date
Application number
IL13998899A
Other languages
English (en)
Original Assignee
Urogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogenesys Inc filed Critical Urogenesys Inc
Publication of IL139988A0 publication Critical patent/IL139988A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL13998899A 1998-06-01 1999-06-01 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer IL139988A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8759898P 1998-06-01 1998-06-01
US9147498P 1998-06-29 1998-06-29
US12952199P 1999-04-14 1999-04-14
PCT/US1999/012253 WO1999062942A2 (fr) 1998-06-01 1999-06-01 Nouvel antigene tumoral utile dans le diagnostic et la therapie propres au cancer de la prostate et du colon

Publications (1)

Publication Number Publication Date
IL139988A0 true IL139988A0 (en) 2002-02-10

Family

ID=27375711

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13998899A IL139988A0 (en) 1998-06-01 1999-06-01 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer

Country Status (12)

Country Link
US (1) US20060275304A1 (fr)
EP (1) EP1082341B1 (fr)
JP (2) JP2002517185A (fr)
AT (1) ATE490977T1 (fr)
AU (2) AU773187B2 (fr)
CA (1) CA2329137C (fr)
CY (1) CY1111906T1 (fr)
DE (1) DE69943020D1 (fr)
DK (1) DK1082341T3 (fr)
IL (1) IL139988A0 (fr)
PT (1) PT1082341E (fr)
WO (1) WO1999062942A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
EP1117794A2 (fr) * 1998-10-02 2001-07-25 Urogenesys, Inc. Gene human 36p1a6 exprime dans le cancer de la prostate, de la vessie, du pancreas et du colon
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000023111A1 (fr) * 1998-10-19 2000-04-27 Diadexus Llc Methode permettant de diagnostiquer, de surveiller, de classer par stades, de visualiser et de traiter le cancer de la prostate
WO2000065067A2 (fr) * 1999-04-23 2000-11-02 University Of Washington Polynucleotides, polypeptides specifiques a la prostate, et leurs procedes d'utilisation
DE60045201D1 (de) 1999-08-12 2010-12-16 Agensys Inc C-Typ-Lektin-Transmembran-Antigen, das in menschlichem Prostatakrebs exprimiert wird, und Verwendungen dieses Antigens
WO2001096390A2 (fr) * 2000-06-09 2001-12-20 Corixa Corporation Compositions et procedes pour la therapie et le diagnostic du cancer du colon
AU2001276361A1 (en) 2000-06-13 2001-12-24 Bayer Aktiengesellschaft Regulation of human transmembrane serine protease
ATE429643T1 (de) * 2000-07-12 2009-05-15 Agensys Inc Neues tumor antigen das für diagnose und therapie von blasen-, eierstock-, lungen- und nierenkrebs verwendet werden kann
US6743592B1 (en) * 2000-07-25 2004-06-01 The Trustees Of The University Of Pennsylvania Methods, systems and kits for immuno-detection of epitopes expressed on molecules
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
US20070275915A1 (en) * 2003-04-15 2007-11-29 Cell Genesys, Inc. Tmprss2 Regulatory Sequences and Uses Thereof
WO2004097358A2 (fr) * 2003-05-02 2004-11-11 Bayer Healthcare Ag Agents diagnostiques et therapeutiques destines a des maladies associees a la serine protease 2 transmembranaire humaine (tmprss2)
JP5512125B2 (ja) 2005-09-12 2014-06-04 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌における再発性遺伝子融合
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
WO2008119767A2 (fr) * 2007-03-30 2008-10-09 Oryzon Genomics, S. A. Procédé d'analyse d'acide nucléique
ES2376509T3 (es) 2007-07-06 2012-03-14 The Regents Of The University Of Michigan Reordenamientos de genes mipol 1-etv1.
WO2009020521A2 (fr) 2007-08-03 2009-02-12 The Brigham And Women's Hospital, Inc. Identification et traitement de tumeurs de la prostate répondant aux œstrogènes
WO2011034906A2 (fr) 2009-09-17 2011-03-24 The Regents Of The University Of Michigan Fusions de gène récurrentes dans le cancer de la prostate
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
PL2814587T3 (pl) * 2012-02-15 2018-10-31 F.Hoffmann-La Roche Ag Chromatografia powinowactwa oparta na receptorze Fc
EP3215528B1 (fr) 2014-11-06 2019-08-07 F.Hoffmann-La Roche Ag Variants du fragment fc caractérisés par une liaison fcrn modifiée et leurs procédés d'utilisation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006692A1 (fr) * 1988-01-12 1989-07-27 Genentech, Inc. Procede de traitement de cellules tumorales par inhibition de la fonction receptrice du facteur de croissance
US5288612A (en) * 1991-07-03 1994-02-22 The Scripps Research Institute Assay methods for detecting serum proteases, particularly activated protein C
EP0679189B1 (fr) * 1993-01-15 2003-06-04 Genetics Institute, LLC Clonage de l'enterokinase et procédé d'utilisation
HUP0002095A3 (en) * 1997-02-25 2002-02-28 Corixa Corp Seattle Compounds for immunotherapy of prostate cancer and methods for their use
US6657056B2 (en) * 1997-02-25 2003-12-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
ES2248891T3 (es) * 1997-02-25 2006-03-16 Corixa Corporation Compuestos para inmunodiagnostico de cancer de prostata y metodos para su uso.
US20030103981A1 (en) * 1997-02-27 2003-06-05 Incyte Genomics, Inc. Methods of use of a prostate-associated protease in the diagnosis and treatment of prostate cancer
US20020119531A1 (en) * 1997-02-27 2002-08-29 Olga Bandman Prostate-associated protease antibody
US6043033A (en) * 1997-02-27 2000-03-28 Incyte Pharmaceuticals, Inc. Human prostate-associated protease
US6500938B1 (en) * 1998-01-30 2002-12-31 Incyte Genomics, Inc. Composition for the detection of signaling pathway gene expression
WO2000000605A1 (fr) * 1998-06-29 2000-01-06 Myriad Genetics, Inc. Tmprss2 agissant comme suppresseur tumoral
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
US6331427B1 (en) * 1999-03-26 2001-12-18 Millennium Pharmaceuticals, Inc. Protease homologs
US20020192763A1 (en) * 2000-04-17 2002-12-19 Jiangchun Xu Compositions and methods for the therapy and diagnosis of prostate cancer
US20020160382A1 (en) * 2000-10-11 2002-10-31 Lasek Amy W. Genes expressed in colon cancer
US20030065157A1 (en) * 2001-04-04 2003-04-03 Lasek Amy W. Genes expressed in lung cancer

Also Published As

Publication number Publication date
AU2004202306B2 (en) 2007-05-24
US20060275304A1 (en) 2006-12-07
WO1999062942A2 (fr) 1999-12-09
DK1082341T3 (da) 2011-03-28
CY1111906T1 (el) 2015-11-04
WO1999062942A3 (fr) 2000-06-02
AU2004202306A1 (en) 2004-06-24
JP2009148265A (ja) 2009-07-09
ATE490977T1 (de) 2010-12-15
CA2329137C (fr) 2011-09-20
EP1082341B1 (fr) 2010-12-08
CA2329137A1 (fr) 1999-12-09
AU4413699A (en) 1999-12-20
JP2002517185A (ja) 2002-06-18
AU773187B2 (en) 2004-05-20
AU2004202306C1 (en) 2008-05-01
DE69943020D1 (de) 2011-01-20
PT1082341E (pt) 2011-02-15
EP1082341A2 (fr) 2001-03-14

Similar Documents

Publication Publication Date Title
CY1111906T1 (el) Αντιγονο ογκων χρησιμο για τη διαγνωση και θεραπεια καρκινου του προστατη και του παχεος εντερου
AU1726199A (en) Metastatic cancer regulated gene
DE69734109D1 (de) Humanisierung von anti-carcinoembryonalen Antigen anti-idiotypischen Antikörper und dessen Verwendung als Tumorvakzin und zur Markierung
Krüger et al. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)
SG96535A1 (en) Pharmaceutical composition for the treatment or prevention of a malignant tumor
ZA953629B (en) Soluble polypeptidic fragments of lag-3 protein method of production thereof therapeutic composition anti-idiotype antibodies
Kuhajda et al. Expression of haptoglobin-related protein and its potential role as a tumor antigen.
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
ATE397062T1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
AU9291198A (en) Apoptosis-related compounds and their use
DK0922223T3 (da) Fremgangsmåde til prognosticering af cancer
Wang et al. Antigen expression associated with lymph node metastasis in gastric adenocarcinomas
CY1109254T1 (el) Νεο αντιγονο ογκου χρησιμο στη διαγνωση και θεραπεια καρκινων της ουροδοχου κυστης, των ωοθηκων, του πνευμονα και του νεφρου
AU2818095A (en) Colon specific gene and protein
Ferrone et al. A human high molecular weight-melanoma associated antigen (HMW-MAA) defined by monoclonal antibodies: a useful marker to radioimage tumor lesions in patients with melanoma
NO991653D0 (no) Immunogenisk tumor frigjorte partikler (TLP)-blanding
WO1998045442A3 (fr) Homologues de f-spondine secretee
WO1994028129A3 (fr) Gene de metastase de tumeur
DE60134956D1 (de) Gene differentiell experimiert in brudtkrebs
WO1998042830A3 (fr) Nouvelles compositions de genes noey2 et leurs utilisations
AU2002360392A1 (en) New gene expressed in prostate cancer and methods of use
AU2003222606A1 (en) Diagnosis of carcinoma using raigi polypeptides
HUP0001270A2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO1999043812A3 (fr) Gene dlc-1: gene putatif suppresseur de tumeurs
EP1693457A3 (fr) Gènes régulés dans les cancers métastatiques du sein et du colon

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees